相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nelotanserin, a Novel Selective Human 5-Hydroxytryptamine(2A) Inverse Agonist for the Treatment of Insomnia
Hussien A. Al-Shamma et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Attenuation of Phencyclidine-Induced Object Recognition Deficits by the Combination of Atypical Antipsychotic Drugs and Pimavanserin (ACP 103), a 5-Hydroxytryptamine2A Receptor Inverse Agonist
S. Snigdha et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
(1R, 3S)-(-)-Trans-PAT: A novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity
Raymond G. Booth et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Assessment of Binding Affinity to 5-Hydroxytryptamine 2A (5-HT2A) Receptor and Inverse Agonist Activity of Naftidrofuryl: Comparison With Those of Sarpogrelate
Saida Abdel Regal Aly et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2009)
Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors
V. J. Aloyo et al.
PHARMACOLOGY & THERAPEUTICS (2009)
The existence of a local 5-hydroxytryptaminergic system in peripheral arteries
W. Ni et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Monoamine Oxidase Inhibitors: A Modern Guide to an Unrequited Class of Antidepressants
Stephen M. Stahl et al.
CNS SPECTRUMS (2008)
Augmented brain 5-HT crosses the blood-brain barrier through the 5-HT transporter in rat
Yasushi Nakatani et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
5-hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats
Jessica Diaz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
A serotonergic system in veins: Serotonin transporter-independent uptake
A. Elizabeth Linder et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Crosstalk of vascular 5-HT1 receptors with other receptors: Clinical implications
Antoinette MaassenVanDenBrink et al.
NEUROPHARMACOLOGY (2008)
5-hydroxytryptamine and cardiovascular regulation
Andrew G. Ramage et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors:: Differential modulation of cell surface expression and signal transduction
Benjamin Chanrion et al.
MOLECULAR PHARMACOLOGY (2008)
Pharmacological evidence that 5-HTIB/ID receptors mediate hypotension in anesthetized rats
Jose A. Terron et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Cardiovascular responses produced by 5-hydroxytriptamine: a pharmacological update on the receptors/mechanisms involved and therapeutic implications
Carlos M. Villalon et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2007)
Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties
Isabelle Rauly-Lestienne et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2007)
β-arrestin-biased ligands at seven-transmembrane receptors
Jonathan D. Violin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors
Terry Kenakin
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Plasma serotonin levels and the platelet serotonin transporter
B. Brenner et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Functional selectivity and classical concepts of quantitative pharmacology
Jonathan D. Urban et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Reanalysis of constitutively active rat and human 5-HT7(a) receptors in HEK-293F cells demonstrates lack of silent properties for reported neutral antagonists
Gonzalo Romero et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2006)
Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT7 serotonin receptor
KA Krobert et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
5-Hydroxytryptamine receptors in the human cardiovascular system
Alberto J. Kaumann et al.
PHARMACOLOGY & THERAPEUTICS (2006)
5-HT in systemic hypertension: foe, friend or fantasy?
SW Watts
CLINICAL SCIENCE (2005)
Stable expression of constitutively activated mutant h5HT6 and h5HT7 serotonin receptors:: inverse agonist activity of antipsychotic drugs
A Purohit et al.
PSYCHOPHARMACOLOGY (2005)
Biomedicine and diseases: Review - Serotonin reuptake inhibitors and cardiovascular diseases: a platelet connection
E Maurer-Spurej
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Evidence for 5-HT2B and 5-HT7 receptor-mediated relaxation in pulmonary arteries of weaned pigs
S Jahnichen et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2005)
Recent advances in understanding serotonin regulation of cardiovascular function
F Côté et al.
TRENDS IN MOLECULAR MEDICINE (2004)
The serotonin transporter is present and functional in peripheral arterial smooth muscle
W Ni et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2004)
5-HT7, but not 5-HT2B, receptors mediate hypotension in vagosympathectomized rats
D Centurión et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
The role of 5-HT on the cardiovascular and renal systems and the clinical potential of 5-HT modulation
SA Doggreu
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2003)
Synthesis of serotonin by a second tryptophan hydroxylase isoform
DJ Walther et al.
SCIENCE (2003)
A unique central tryptophan hydroxylase isoform
DJ Walther et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Localization of norepinephrine and serotonin transporter in mouse brain capillary endothelial cells
K Wakayama et al.
NEUROSCIENCE RESEARCH (2002)
5-hydroxytryptamine2B receptor function is enhanced in the Nω-nitro-L-arginine hypertensive rat
A Russell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
The optimal dosage of ketanserin for patients with severe hypertension in pregnancy
DL van Schie et al.
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2002)
Molecular, pharmacological and functional diversity of 5-HT receptors
D Hoyer et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Hemodynamic responses of broiler pulmonary vasculature to intravenously infused serotonin
ME Chapman et al.
POULTRY SCIENCE (2002)
Upregulation of arterial serotonin 1B and 2B receptors in deoxycorticosterone acetate-salt hypertension
AKL Banes et al.
HYPERTENSION (2002)
Modern views on an ancient chemical: Serotonin effects on cell proliferation, maturation, and apoptosis
EC Azmitia
BRAIN RESEARCH BULLETIN (2001)
A novel role for serotonin in heart
CG Nebigil et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2001)
Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)1B and h5-HT1D receptors
V Audinot et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist but not antagonist binding to 5-HT2c receptors after chronic treatment
J Hietala et al.
PSYCHOPHARMACOLOGY (2001)
S 14506:: novel receptor coupling at 5-HT1A receptors
G Milligan et al.
NEUROPHARMACOLOGY (2001)
Constitutive activity at serotonin 5-HT1D receptors: detection by homologous GTP gamma S versus [S-35]-GTP gamma S binding isotherms
V Audinot et al.
NEUROPHARMACOLOGY (2001)
The effect of SB-236057-A, a selective 5-HT1B receptor inverse agonist, on in vivo extracellular 5-HT levels in the freely-moving guinea-pig
C Roberts et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2000)
The putative silent 5-HT1A receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT1A receptors
C Cosi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Serotonin syndrome - Presentation of 2 cases and review of the literature
PJ Mason et al.
MEDICINE (2000)
Fluoxetine-induced presser response in freely moving rats: a role for vasopressin and sympathetic tone
E Lazartigues et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2000)
分享论文
